Open AccessThe Impact of Upcoming Treatments in Huntington’s Disease: Resource Capacity Limitations and Access to Care Implications
Author(s) -
Mark Guttman,
Marco Pedrazzoli,
М. А. Пономарева,
Marsha Pelletier,
Louisa Townson,
K. Mukelabai,
Aaron Levine,
Anna-Leordström,
Ralf Reilmann,
JeanMarc Burgunder
Publication year - 2021
Publication title -
journal of huntington's disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.081
H-Index - 24
eISSN - 1879-6400
pISSN - 1879-6397
DOI - 10.3233/jhd-200462
Subject(s) - medicine , health care , resource (disambiguation) , disease , business , huntington's disease , capacity building , administration (probate law) , nursing , medical emergency , political science , computer science , computer network , pathology , law
The most advanced disease-modifying therapies (DMTs) in development for Huntington's disease (HD) require intrathecal (IT) administration, which may create or exacerbate bottlenecks in resource capacity.